A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants
Clinical trial NCT03444818 · COMPLETED
Trial details
- NCT number
- NCT03444818
- Sponsor
- EA Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2018-06-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.